Levacetylleucine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Levacetylleucine. Educational only — not medical advice.

Labeled uses

AQNEURSA™ is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg.

Source: FDA labeling via NIH DailyMed (set 0f248e55…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.